“How much does it cost to get treated for depression?”

For many people, considerably less than they expect.

Depression usually does not require an expensive diagnostic test. A detailed psychiatric consultation in Chennai may cost roughly ₹750–₹2,000, although senior specialists and corporate hospitals may charge more. Current Chennai listings show many psychiatry consultations for depression around ₹950–₹2,000.

For a straightforward depressive episode, diagnosis may require little more than:

a careful psychiatric interview,
assessment of severity and functioning,
evaluation of suicide risk,
screening for bipolar disorder and other psychiatric conditions,
review of medications, substances and relevant medical problems,
and, where useful, a standardized scale such as the PHQ-9.

Medication can also be relatively inexpensive in India.

Where costs begin to rise is when the patient requires regular psychotherapy, extensive medical investigation, repeated unsuccessful treatments, hospitalization, rTMS, ketamine treatment or ECT.

A practical way of looking at depression treatment in Chennai is therefore:

Basic psychiatric assessment: approximately ₹750–₹2,000+
Medication: often a few hundred rupees per month
Psychotherapy: commonly ₹1,500–₹2,500 or more per session
10–15 therapy sessions: potentially ₹15,000–₹37,500+
Treatment-resistant depression: potentially much more if interventional treatments are required

The key message is:

Depression is usually inexpensive to diagnose. The cost depends primarily on severity, duration and how much treatment is required to achieve recovery.

First: Depression Is Not Simply Sadness

Everyone feels sad occasionally.

Bereavement, relationship difficulties, examination failure, financial stress and workplace problems naturally produce emotional distress.

That does not automatically mean someone has Major Depressive Disorder.

Clinical depression usually involves a persistent cluster of symptoms that may include:

low mood,
loss of interest or pleasure,
reduced energy,
impaired concentration,
disturbed sleep,
appetite or weight changes,
excessive guilt,
hopelessness,
slowed or agitated behaviour,
thoughts about death or suicide.

The critical issue is not merely:

“Are you sad?”

It is:

“Has there been a significant change in mood, thinking, biological functioning and everyday ability—and what is causing it?”

Level 1: Psychiatric Consultation — Approximately ₹750–₹2,000+

For most people, this is the main diagnostic investigation.

Current Chennai listings show psychiatrists seeing patients with depression at fees including approximately ₹750, ₹950, ₹1,250, ₹1,500 and ₹2,000, although individual fees can be higher.

A good depression assessment should explore much more than mood.

It should examine:

duration of symptoms,
previous episodes,
sleep,
appetite,
energy,
concentration,
motivation,
work or academic performance,
relationships,
anxiety,
alcohol and substance use,
medical illness,
current medications,
family psychiatric history,
previous antidepressant treatment,
suicidal thoughts,
manic or hypomanic symptoms.

That final point—screening for bipolarity—is particularly important.

Before Calling It Depression, Ask: Could This Be Bipolar Disorder?

One of the most consequential mistakes in mood-disorder assessment is diagnosing every depressive episode as unipolar depression.

A person may present during a depressive phase but have previously experienced periods of:

unusually elevated or irritable mood,
markedly reduced need for sleep,
excessive confidence,
increased activity,
unusually rapid speech,
racing thoughts,
impulsive spending,
risky behaviour,
increased sexual drive,
unrealistic projects.

If these represent mania or hypomania, the treatment formulation changes substantially.

Therefore a good depression assessment is not simply:

“PHQ-9 high = antidepressant.”

The clinician needs to understand the longitudinal mood history.

Level 2: PHQ-9 and Other Depression Scales

Structured rating scales can be very useful.

The Patient Health Questionnaire-9, or PHQ-9, is widely used to quantify depressive symptoms.

Other instruments may also be used depending on the setting, including clinician-rated scales such as the Hamilton Depression Rating Scale or Montgomery-Åsberg Depression Rating Scale.

These measures can help:

establish baseline severity,
monitor response,
identify residual symptoms,
quantify improvement over time.

But the same distinction applies as in anxiety and OCD:

A depression questionnaire measures symptoms. It does not replace diagnosis.

Someone can score highly because of:

bereavement,
bipolar depression,
severe anxiety,
chronic pain,
medical illness,
substance use,
sleep deprivation,
another psychiatric disorder.

The score must be interpreted clinically.

Does Depression Require Blood Tests?

Not routinely.

There is no blood test that says:

“Depression positive.”

For many otherwise healthy adults with a typical presentation, extensive laboratory investigation may not be necessary.

But targeted investigations can be useful when the history suggests a possible medical contributor.

Depending on the individual, clinicians may consider:

complete blood count,
thyroid function,
blood glucose,
vitamin B12,
folate,
liver and kidney function,
electrolytes,
vitamin D in selected circumstances,
hormonal or other investigations when clinically indicated.

The principle should be:

Test because there is a clinical question—not simply because depression has been diagnosed.

Why Thyroid, Anaemia and Nutritional Problems Sometimes Matter

Several medical conditions can resemble or worsen depressive symptoms.

For example, hypothyroidism may contribute to:

fatigue,
cognitive slowing,
low mood,
weight change.

Anaemia can produce:

tiredness,
reduced exercise tolerance,
concentration difficulty.

Vitamin deficiencies may occasionally contribute to neurological or psychiatric symptoms.

Chronic inflammatory, endocrine, neurological and other illnesses can also affect mood.

But ordering every available laboratory test for every person with mild depression is unlikely to be good value.

A clinical assessment should determine which investigations are justified.

Do We Need an MRI, EEG or QEEG to Diagnose Depression?

Usually, no.

Routine depression diagnosis does not require:

MRI,
CT,
EEG,
QEEG,
PET,
brain mapping.

These tests may become relevant when there is another clinical indication—for example neurological symptoms, seizures, cognitive decline, unusual late-onset psychiatric symptoms or another suspected medical condition.

But there is currently no routine brain scan that independently tells us:

“This patient has Major Depressive Disorder.”

Technology may become increasingly useful in predicting treatment response and understanding depressive disorders, but it should complement rather than replace psychiatric assessment.

Mild Depression Does Not Automatically Require Medication

This point is often overlooked.

For less severe depression, contemporary NICE guidance recommends considering lower-intensity and less resource-intensive approaches first and specifically advises not routinely offering antidepressants as first-line treatment for less severe depression unless that is the person’s informed preference.

Options may include:

guided self-help,
behavioural activation,
structured exercise,
CBT-based interventions,
problem-solving approaches,
addressing sleep,
reducing alcohol or substance use,
correcting major lifestyle disruption,
psychological treatment.

This makes clinical and economic sense.

Not everyone experiencing a mild depressive episode requires indefinite medication plus weekly psychotherapy.

Treatment Option 1: Antidepressant Medication

For more significant depression, antidepressants are one evidence-based treatment option.

Commonly used medication classes include:

SSRIs,
SNRIs,
mirtazapine,
vortioxetine,
and other antidepressants depending on the clinical circumstances.

NICE notes that SSRIs are generally well tolerated and have a favourable safety profile, and they are often considered first-choice antidepressants for many patients requiring medication.

Medication choice should take into account:

previous response,
side effects,
sleep,
appetite,
sexual function,
weight concerns,
anxiety,
other medications,
physical health,
suicide risk,
pregnancy considerations where relevant.

The cheapest medicine is not necessarily the most appropriate medicine.

But many commonly used antidepressants are inexpensive in India.

How Much Do Antidepressants Cost in India?

Prices vary considerably by molecule and brand.

As of September 2026, current online pharmacy prices illustrate this well.

Generic sertraline 50 mg preparations can be found for roughly ₹36–₹47 for ten tablets, while some branded versions of the same molecule cost more than ₹100 or even ₹200 per strip.

Generic fluoxetine 20 mg preparations are currently listed around ₹43–₹64 for 10–15 capsules.

One escitalopram 10 mg preparation is currently listed at approximately ₹72 for ten tablets.

Therefore, for many uncomplicated cases, the medication cost may remain only a few hundred rupees per month.

Higher doses, premium brands, combinations or newer medications can increase the cost.

These examples are retail price illustrations—not prescribing recommendations.

Medication Is Often Not the Expensive Part of Depression Treatment

Consider someone whose antidepressant costs ₹300 per month.

Six months would cost approximately:

₹1,800.

Now compare that with psychotherapy costing ₹2,000 per session.

Ten sessions:

₹20,000

Sixteen sessions:

₹32,000

This is why, as with anxiety and OCD, professional therapy time frequently becomes the larger direct financial component.

Treatment Option 2: Psychotherapy

Depression is not treated by medication alone.

Evidence-based psychological interventions include:

Cognitive Behaviour Therapy,
Behavioural Activation,
Interpersonal Psychotherapy,
problem-solving approaches,
guided self-help,
other structured therapies depending on the individual.

Psychotherapy becomes particularly valuable when depression is being maintained by factors such as:

avoidance,
withdrawal,
rumination,
dysfunctional beliefs,
relationship difficulties,
unresolved interpersonal conflicts,
poor coping,
recurrent patterns of behaviour.

NICE places several structured psychological treatments among evidence-based first-line options and describes individual CBT for more severe depression as commonly involving around 16 regular sessions, with additional sessions in more complex cases.

How Much Does Therapy for Depression Cost in Chennai?

Current Chennai depression and psychology listings demonstrate a wide range.

Many individual psychiatrists and psychologists are listed around ₹950–₹2,000 per consultation, while broader counselling prices can range considerably higher.

For planning purposes, a private psychotherapy fee of approximately ₹1,500–₹2,500 per session is a useful working range for many Chennai services, although fees vary substantially.

That gives an illustrative cost of:

5 sessions

₹7,500–₹12,500

10 sessions

₹15,000–₹25,000

16 sessions

₹24,000–₹40,000

These are not fixed Chennai tariffs.

They simply illustrate why sustained psychotherapy can cost significantly more than medication.

What Is Behavioural Activation?

Behavioural Activation deserves particular attention because it is conceptually simple and clinically useful.

Depression often creates a vicious cycle:

Low mood → reduced activity → withdrawal → fewer rewarding experiences → worsening mood → even less activity.

A depressed person may gradually stop:

exercising,
meeting friends,
pursuing hobbies,
working effectively,
leaving home,
maintaining routines.

Behavioural Activation systematically reverses this pattern.

The aim is not:

“Wait until you feel motivated, then start living.”

It is closer to:

“Start rebuilding meaningful activity, even before motivation completely returns.”

For some patients this is an extremely useful component of treatment.

CBT Is Not Simply Positive Thinking

Another misconception is that CBT means telling a depressed person:

“Think positively.”

That is not good CBT.

Structured CBT examines the relationship between:

situations,
thoughts,
emotions,
behaviour,
underlying beliefs.

It attempts to identify cognitive and behavioural processes that maintain depression and test alternative ways of responding.

The objective is not artificial optimism.

It is more accurate and flexible thinking combined with behavioural change.

Medication or Therapy: Which Is Better Value?

There is no universal winner.

For one person with mild depression, structured behavioural intervention may be sufficient.

For another with significant biological symptoms, profound loss of energy and severe impairment, medication may be appropriate.

For a third person with severe depression, combining antidepressant medication with structured psychotherapy may provide the best approach.

NICE lists combined individual CBT plus an antidepressant among first-line options for more severe depression.

Treatment should therefore be matched to:

severity,
previous treatment,
patient preference,
recurrent episodes,
comorbidities,
suicide risk,
functional impairment.

Depression Treatment Should Be Measured

One major improvement in psychiatric practice is measurement-based care.

Suppose a patient begins treatment with:

PHQ-9 = 22.

After six weeks:

PHQ-9 = 19.

That is very different from:

PHQ-9 = 7.

Both patients may say:

“I feel slightly better.”

But objective symptom tracking can reveal whether treatment is producing meaningful improvement.

Measurement does not replace conversation.

It makes the conversation more precise.

A structured approach can track:

depressive symptoms,
sleep,
functioning,
side effects,
suicidality,
cognitive complaints,
treatment adherence.

When Should We Say an Antidepressant Has “Failed”?

Not after three tablets.

Depression treatment requires adequate dose, duration and adherence before response can be judged properly.

NICE notes that benefits from antidepressant treatment should generally begin to become apparent within around 4 weeks, while regular review is required to assess effectiveness, side effects and safety.

Before calling a medication ineffective, clinicians should ask:

Was the medication actually taken?
Was the dose adequate?
Was the duration adequate?
Were intolerable side effects limiting treatment?
Was the diagnosis correct?
Is this bipolar depression?
Is alcohol or substance use interfering?
Is severe insomnia continuing?
Is there an untreated medical condition?
Is ADHD, anxiety, OCD or another psychiatric disorder present?

Changing medication repeatedly without answering these questions can become expensive and frustrating.

Depression or ADHD?

This is an increasingly important differential diagnosis.

Both can produce:

poor concentration,
procrastination,
low motivation,
inconsistent performance,
executive dysfunction,
sleep difficulties.

The timeline matters.

If someone functioned normally throughout childhood and adulthood and concentration deteriorated only after becoming depressed, cognitive problems may be secondary to depression.

If disorganisation, procrastination, distractibility and deadline problems have existed since childhood, with depression developing later after years of functional difficulties, ADHD deserves consideration.

Treating the wrong primary condition can lead to repeated treatment failures.

Depression or Dementia?

This distinction becomes particularly important in older adults.

Depression can cause:

poor memory,
slowed thinking,
concentration difficulty,
reduced motivation,
impaired executive function.

Sometimes the presentation resembles dementia.

Conversely, early neurodegenerative illness can initially appear as depression, apathy or personality change.

In such cases, cognitive assessment may become valuable.

The correct question is not simply:

“Is this depression?”

It may be:

“Is this depression causing cognitive impairment, dementia presenting psychiatrically, or both?”

Depression With Suicidal Thoughts Is Different

Cost discussions become secondary when safety is at stake.

A person with depression may experience:

thoughts that life is not worth living,
wishes not to wake up,
recurrent thoughts about death,
active suicidal thoughts,
planning,
preparatory behaviour.

The clinician needs to assess:

intent,
plan,
means,
previous attempts,
substance use,
impulsivity,
social support,
protective factors.

Some patients can be managed safely as outpatients.

Others may require intensive monitoring or hospitalization.

Severe suicidal depression should therefore not be reduced to:

“Which antidepressant is cheapest?”

Safety comes first.

When Depression Becomes Treatment-Resistant

Most patients should not be labelled “treatment resistant” simply because the first medicine did not work.

Before reaching that conclusion, the clinician should reconsider:

Was the diagnosis correct?

Were adequate treatments actually tried?

Was the medication taken consistently?

Is there bipolarity?

Is another psychiatric disorder present?

Is a medical condition contributing?

Has psychotherapy been properly used?

When genuinely adequate treatment has produced limited response, the options broaden.

NICE recommends considering dose optimization, switching antidepressants, psychological treatment, combined approaches and—in specialist care—augmentation strategies depending on the patient’s situation.

This is where depression treatment can become substantially more expensive.

Level 3: rTMS

Repetitive Transcranial Magnetic Stimulation, or rTMS, uses magnetic stimulation to modulate targeted brain circuits.

It is non-invasive and does not require general anaesthesia.

It has an established role particularly in patients with depression who have not responded adequately to conventional treatment.

The main financial issue is that rTMS is generally not one treatment session.

A course may involve 20–30 or more sessions.

Published 2026 Indian private-sector estimates commonly place rTMS around ₹1,500–₹5,000 per session, with complete courses often ranging from roughly ₹30,000 to ₹1 lakh or more, depending on the centre and protocol.

These are broad Indian estimates, not fixed Chennai prices.

The appropriate question is therefore not:

“How much is one rTMS session?”

but:

“What is the expected complete treatment course and total cost?”

Level 4: Ketamine-Based Treatment

Ketamine has emerged as an important rapid-acting treatment option in selected patients with difficult-to-treat depression.

It is not appropriate as routine first-line treatment for every depressed patient.

But in carefully selected patients—particularly in specialist settings—it may become part of the treatment discussion.

Published Indian private-sector estimates vary substantially, with some 2026 sources placing supervised ketamine treatments around ₹8,000–₹20,000 per infusion, while other centres report wider ranges.

Again, these are indicative Indian market estimates rather than standard Chennai tariffs.

The total cost depends on:

route of administration,
monitoring requirements,
number of sessions,
hospital or clinic setting,
maintenance treatment.

Ketamine should therefore be thought of as a specialist intervention, not an expensive shortcut around ordinary depression treatment.

Level 5: Electroconvulsive Therapy

ECT remains one of psychiatry’s most effective treatments for certain forms of severe depression.

It may be particularly considered in situations such as:

severe depressive illness,
psychotic depression,
catatonia,
severe suicidality,
profound food or fluid refusal,
previous strong ECT response,
situations where a rapid clinical response is particularly important.

Modern ECT is performed under anaesthesia with muscle relaxation.

Private-sector costs vary according to:

anaesthesia,
hospital charges,
investigations,
number of sessions,
inpatient versus outpatient treatment.

Published Chennai cost listings vary widely, with one aggregator currently estimating approximately ₹2,000–₹7,000 per ECT session, while national hospital estimates can be considerably higher.

These figures should be treated cautiously because hospital billing structures differ considerably.

The key clinical point is that ECT should not be judged by the price of one session—the complete treatment course and clinical indication matter.

A Practical Depression Cost Framework in Chennai

Level 1 — Straightforward Depression

Possible costs:

Psychiatrist consultation: ₹750–₹2,000+
Rating scale: usually incorporated
Investigations: none or selective
Medication: often a few hundred rupees monthly
Periodic follow-up: depending on clinical need

For many patients, depression treatment can therefore remain quite affordable.

Level 2 — Depression Requiring Psychotherapy

Possible treatment:

psychiatric assessment,
medication if indicated,
8–16 structured therapy sessions,
monitoring and follow-up.

At ₹1,500–₹2,500 per therapy session:

10 sessions: ₹15,000–₹25,000
16 sessions: ₹24,000–₹40,000

At this level, psychotherapy usually becomes the major expense.

Level 3 — Complex or Treatment-Resistant Depression

Costs may include:

repeated specialist assessments,
medication optimization,
combination or augmentation treatment,
structured psychotherapy,
medical investigations,
rTMS,
ketamine,
ECT,
hospitalization where necessary.

Overall treatment can then move from thousands into tens of thousands of rupees or more.

But importantly:

Most people presenting with depression do not need to begin at Level 3.

Expensive Treatment Should Not Replace Accurate Diagnosis

A patient who has failed three antidepressants does not automatically need rTMS.

A patient who has failed rTMS does not automatically need ketamine.

Before escalating treatment, return to the formulation.

Could this be:

bipolar disorder?
ADHD?
OCD?
PTSD?
substance-related?
personality-related difficulties?
sleep disorder?
hypothyroidism?
another medical condition?
severe psychosocial stress without Major Depressive Disorder?

The more expensive the proposed intervention, the more important diagnostic accuracy becomes.

The Cost of Untreated Depression Is Often Greater Than the Clinic Bill

Depression has indirect costs that are difficult to calculate.

A person may:

stop performing effectively at work,
repeatedly take leave,
fail examinations,
withdraw from relationships,
abandon exercise,
neglect physical illness,
lose employment opportunities,
become dependent on family members.

Someone earning ₹1 lakh per month who loses several months of productive functioning has incurred a cost far greater than a ₹1,500 psychiatric consultation.

That is why the meaningful economic question is not simply:

“How much does psychiatry cost?”

It is:

“How much functioning is being lost because the illness remains untreated?”

What Should a Good Depression Assessment Ultimately Provide?

At the end of the evaluation, the patient should understand:

Is this actually depression?

How severe is it?

Could this be bipolar disorder?

Is anxiety, ADHD, OCD, substance use or another condition contributing?

Do I require medical investigations?

Do I need medication?

Would psychotherapy help?

What symptoms should improve first?

How will we measure response?

How long should treatment continue?

What happens if the first treatment does not work?

And, crucially:

Is there any suicide risk requiring more urgent intervention?

That is much more useful than receiving a prescription after a five-minute conversation.

Depression Assessment and Treatment in Chennai

My approach to depression begins with diagnostic accuracy before treatment escalation.

The first task is to establish whether the presentation represents:

Major Depressive Disorder,
bipolar depression,
anxiety with secondary low mood,
ADHD-related demoralisation,
adjustment-related distress,
another psychiatric condition,
or depression associated with a medical disorder.

Where useful, validated symptom scales can provide a baseline and allow treatment response to be measured rather than relying entirely on impressions.

For straightforward depression, treatment can remain relatively simple and affordable.

When psychotherapy is required, treatment should be structured and goal-directed, using evidence-based approaches rather than indefinite counselling without clear outcome measures.

And when depression genuinely proves resistant to conventional treatment, modern psychiatry offers a second level of options including rTMS, ketamine-based approaches and ECT in appropriately selected patients.

The goal should not be to move rapidly toward the newest or most expensive intervention.

It should be:

make the correct diagnosis, measure severity, start with an appropriate evidence-based treatment, measure the response and escalate rationally only when necessary.

Dr. Srinivas Rajkumar T

Senior Consultant Psychiatrist
MD Psychiatry — AIIMS New Delhi

Clinical interests include Depression, Treatment-Resistant Depression, Anxiety, OCD, ADHD, Cognitive Assessment and Interventional Psychiatry

Apollo Clinic — Velachery, Chennai

Opposite Phoenix Market City

Appointments: +91 85951 55808
Email: srinivasaiims@gmail.com

Depression is usually inexpensive to diagnose and, for many patients, inexpensive to treat. The cost rises when illness becomes prolonged or resistant—which is precisely why accurate diagnosis and systematic treatment early in the course matter.